Summary by Moomoo AI
TENSHENGBO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (TENSHENG BO PHARMACEUTICAL-B) HAS ISSUED A NOTICE TO SHAREHOLDERS ON 26 APRIL 2024 THAT THE 2023 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM (THIS COMPANY'S NEWSLETTER) AND 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT (ESG REPORT) WILL BE AVAILABLE Obtained on the Company's website and the United Stock Exchange Limited. Shareholders may choose to receive future corporate newsletters in printed or online versions. The Company provides a Change Request Form for shareholders to change the language version and means of receipt of the Company's communications. In addition, the Company confirms that printed copies will be provided free of charge if shareholders have difficulty receiving the online version. THE COMPANY EMPHASIZES THAT ALL FUTURE CORPORATE NEWSLETTERS WILL BE AVAILABLE IN PRINT AND ONLINE VERSIONS AND THAT SHAREHOLDERS ARE ENCOURAGED TO CONTACT THE HONG KONG SHARE TRANSFER OFFICE IF NECESSARY.